Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.78
+1.06 (1.18%)
At close: Jun 26, 2026, 4:00 PM EDT
91.35
+0.57 (0.63%)
After-hours: Jun 26, 2026, 7:11 PM EDT

Edwards Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
52,27149,50543,57445,83445,38580,852
Market Cap Growth
18.07%13.61%-4.93%0.99%-43.87%41.96%
Enterprise Value
49,28245,98440,36344,95644,86180,076
Last Close Price
90.7885.2574.0376.2574.61129.55
PE Ratio
49.1946.5810.6233.1530.5854.43
Forward PE
29.6330.9331.1928.4130.3552.98
PEG Ratio
2.463.243.692.772.953.38
PS Ratio
8.298.168.019.1510.1715.45
PB Ratio
5.074.794.366.897.8213.85
P/TBV Ratio
7.286.716.309.1010.6918.82
P/FCF Ratio
47.9837.08150.3171.3046.6257.49
P/OCF Ratio
38.4731.0380.3551.1737.2646.68
EV/Sales Ratio
7.827.587.428.9710.0515.30
EV/EBITDA Ratio
25.8932.3626.3130.9227.3943.87
EV/EBIT Ratio
28.2836.3729.2834.3529.9447.37
EV/FCF Ratio
45.2334.44139.2369.9446.0856.94
Debt / Equity Ratio
0.070.070.070.100.110.11
Debt / EBITDA Ratio
0.470.500.460.470.420.38
Debt / FCF Ratio
0.650.532.421.070.710.49
Net Debt / Equity Ratio
-0.29-0.34-0.33-0.14-0.09-0.13
Net Debt / EBITDA Ratio
-1.97-2.48-2.14-0.65-0.32-0.42
Net Debt / FCF Ratio
-2.72-2.64-11.30-1.47-0.54-0.55
Asset Turnover
0.470.450.490.570.530.66
Inventory Turnover
1.241.211.121.100.901.63
Quick Ratio
3.302.833.122.061.872.07
Current Ratio
4.423.724.183.383.033.08
Return on Equity (ROE)
10.39%10.39%16.70%19.48%22.74%28.88%
Return on Assets (ROA)
8.24%7.84%11.09%13.18%15.55%18.97%
Return on Invested Capital (ROIC)
13.97%13.73%17.40%18.23%21.56%27.15%
Return on Capital Employed (ROCE)
11.32%10.79%13.98%16.96%20.33%24.47%
Earnings Yield
2.10%2.15%9.42%3.02%3.27%1.84%
FCF Yield
2.08%2.70%0.67%1.40%2.15%1.74%
Buyback Yield / Dilution
1.88%2.25%1.66%2.37%1.11%0.11%
Total Shareholder Return
1.88%2.25%1.66%2.37%1.11%0.11%
SEC Filings: 10-K · 10-Q